3-(Naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride attenuates MPP＋-induced cytotoxicity by regulating oxidative stress and mitochondrial dysfunction in SH-SY5Y cells

키워드

참고문헌 (30)

1. Gazewood JD, "Parkinson disease: an update", Am Fam Physician, 87, pp.267~273 (2013)
2. Smeyne M, "Glutathione metabolism and Parkinson's disease", Free Radic Biol Med, 62, pp.13~25 (2013)
3. Malkus KA, "Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson’s disease: how neurons are lost in the Bermuda triangle", Mol Neurodegener, 4, pp.24~ (2009)
4. Bloem BR, "The MPTP model: versatile contributions to the treatment of idiopathic Parkinson’s disease", J Neurol Sci, 97, pp.273~293 (1990)
5. Cleeter MW, "Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement", J Neurochem, 58, pp.786~789 (1992)
6. Yi F, "Lycopene protects against MPP＋-induced cytotoxicity by maintaining mitochondrial function in SH-SY5Y cells", Neurochem Res, 38, pp.1747~1757 (2013)
7. Ojha S, "Betacaryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease", Mol Cell Biochem, 418, pp.59~70 (2016)
8. Lowe JT, "Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries", J Org Chem, 77, pp.7187~7211 (2012)
9. Han Y, "Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors", J Med Chem, 55, pp.8188~8192 (2012)
10. Dalla Y, "Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice", Indian J Pharmacol, 41, pp.262~267 (2009)
11. 김지애, "Protective effect of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on hypoxia-induced toxicity by suppressing microglial activation in BV-2 cells", BMB Reports, 49(12), pp.687~692 (2016), 생화학분자생물학회
12. Kim EA, "Neuroprotective effect of 3-(naphthalen-2-yl(propoxy)methyl) azetidine hydrochloride on brain ischaemia", reperfusion injury, 2017, pp.12, 447~461
13. Kim EA, "Anti-oxidative and anti-inflammatory effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on glutamate-induced neurotoxicity in rat brain", Neurotoxicol, 38, pp.106~114 (2013)
14. Cho CH, "N-adamantyl-4-methylthiazol-2-amine suppresses lipopolysaccharideinduced brain inflammation by regulating NF-B signaling in mice", J Neuroimmunol, 289, pp.98~104 (2015)
15. Rosa AI, "Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease", Biochim Biophys Acta-Mol Basis Dis, 1863, pp.2171~2181 (2017)
16. Hu XL, "Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement", Neuropharmacology, 117, pp.352~363 (2017)
17. Choi WS, "Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis", J Neurochem, 74, pp.1621~1626 (2000)
18. Borner C, "The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions", Mol Immunol, 39, pp.615~647 (2003)
19. Ghosh A, "Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model", Free Radic Biol Med, 49, pp.1674~1684 (2010)
20. Ramalingam M, "The role of insulin against hydrogen peroxide-induced oxidative damages in differentiated SH-SY5Y cells", J Recept Signal Transduct, 34, pp.212~220 (2014)
21. Song JX, "Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP＋, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells", Neurosci Lett, 521, pp.76~81 (2012)
22. Chung HK, "Relationship between dietary folate intake and plasma monocyte chemoattractant protein-1 and interleukin-8 in heart failure patients", J Clin Biochem Nutr, 49, pp.62~66 (2011)
23. Ho PW, "Knockdown of uncoupling protein-5 in neuronal SHSY5Y cells: effects on MPP＋-induced mitochondrial membrane depolarization, ATP deficiency, and oxidative cytotoxicity", J Neurosci Res, 84, pp.1358~1366 (2006)
24. Liu B, "Role of nitric oxide in inflammation-mediated neurodegeneration", Ann NY Acad Sci, 962, pp.318~331 (2002)
25. Obata T, "Nitric oxide and MPP＋-induced hydroxyl radical generation", J Neural Transm, 113, pp.1131~1144 (2006)
26. Yürekli VA, "Zonisamide attenuates MPP＋-induced oxidative toxicity through modulation of Ca2＋ signaling and caspase-3activity in neuronal PC12 cells", Cell Mol Neurobiol, 33, pp.205~212 (2013)
27. Lin LF, "GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons", Science, 260, pp.1130~1132 (1993)
28. d'Anglemont de Tassigny X, "GDNF based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease", Front Neuroanat, 9, pp.10~ (2015)
29. Lindholm D, "Current disease modifying approaches to treat Parkinson's disease", Cell Mol Life Sci, 73, pp.1365~1379 (2016)
30. Cheng YF, "GPR30 activation contributes to the puerarin-mediated neuroprotection in MPP＋-induced SH-SY5Y cell death", J Mol Neurosci, 61, pp.227~234 (2017)

관련 논문AI추천